Front > HEALTHCARE

HEALTHCARE

Cannabis inhaler co Syqe Medical lays off 50

The company says it is making structural adjustments, mainly in the development department.

Maurice Ferre illustration Gil Gibli Insightec wins new FDA approval for Parkinson's treatment

The company's revenue is growing, but it is yet to post a profit. CEO Maurice Ferré: The market no longer tolerates losses.

Synchronization between organs  credit: Shutterstock Tuning the body's "orchestra" might slow ageing - Israeli study

Haifa University researchers have found that synchronization between organs declines with age, opening up new possibilities for diagnostics, and perhaps even intervention.

Restore Medical team credit: Yael Ilan Israeli co Restore Medical raises $23m

The company's transcatheter approach introduces a new minimally invasive therapeutic option for heart failure patients who have limited effective treatments today.

Imagene founders Shahar Porat, Dean Bitan, and Jonathan Zalach   credit: Eyal Toueg Precision medicine co Imagene AI raises $23m led by Larry Ellison

The Israeli company is developing AI-based personalized medicines in collaboration with Oracle.

Richard Francis  credit: Elad Malka Teva launches startup challenge program

Challenges will be announced twice a year for startups to offer technological solutions for Teva's entire drug development chain.

Weizmann institute of Science credit: Shutterstock Weizmann Institute launches crowdfunding campaign

Besides its regular donors, the institute is asking the general public to help restore facilities hit by an Iranian missile. Ben Gurion University has embarked on a similar campaign.

ForSight Robotics founders credit: ForSight Israeli ophthalmic surgery co ForSight Robotics raises $125m

The company has developed the ORYOM robotic surgery platform for cataract and other eye diseases.

Med-tech credit: Shutterstock Israeli startup Lembas unveils food additive for slimming

The company has emerged from stealth and announced that it has raised $3.6 million in a pre-seed financing round.

Dikla Czaczkes Akselbrad  credit: Yossi Lazarov PolyPid reports positive phase 3 surgical infection drug trial

The Israeli company's treatment is a delayed-release antibiotic administered in the area where the patient has undergone surgery.

Life sciences investment panel credit: PR Life sciences funding meets challenges in changing market

Investors highlighted challenges and strategic models in life sciences funding, in a forum co-hosted by Lipa Meir & Co.

Richard Francis  credit: Elad Malka Teva gives aggressive guidance for innovative drugs

The company sees revenue from its leading products doubling to $5 billion by 2030.

Teva CEO Richard Francis credit: Teva Spokesperson Teva recycling debt after rating upgrade

The Israeli pharmaceutical company's debt at the end of the first quarter of 2025 was $16.7 billion, after the company repaid $1.4 billion in debt during the quarter.

Healthcare bureaucracy  credit: Shutterstock/Andrey Popov Israeli companies streamlining US healthcare

Over the past 15 years, Israeli startups have been applying Big Data to cure the US healthcare system’s ills. How do they do it, and can they maintain their advantage?

Micha Breakstone  credit: Jonathan Bloom AI cell therapy development co Somite raises $47m

Somite AI is building DeltaStem, a platform and foundation model designed to revolutionize the production of human cells.

Teva  credit: Cineberg/Shutterstock Trump post on slashing drug prices sends Teva tumbling

Pharma companies everywhere have been hit by the US president's announcement that he will cut prices of drugs to their lowest prices globally.

Teva's R&D labs in Netanya  credit: Teva PR Teva to lay off an estimated 250-300 employees in Israel

Market sources believe that the rate of layoffs in Israel will be similar to the general rate worldwide.

Teva CEO Richard Francis credit: Teva Spokesperson Teva on course for 2027 targets

The Israeli pharmaceutical company's 3,000 layoffs will help the company achieve its targets for growth and higher profitability.

Teva CEO Richard Francis credit: Elad Malka Teva to lay off 3,000 employees

The Israeli pharmaceutical company unexpectedly announced the layoffs after publishing its first quarter results.

Tel Aviv University  credit: Shutterstock Tel Aviv University medical school receives $125m donation

The donation, from Blackstone president Jon Gray and his wife Mindy, will enable the university's Faculty of Medical and Health Sciences to expand both in medical studies and research.

Teva CEO Richard Francis credit: Sivan Faraj Teva receives FDA approval for biosimilar

The FDA has ruled that SELARSDI, which Teva has launched with Alvotech, is interchangeable with Stelara for treating adult and pediatric psoriatic arthritis and plaque psoriasis, as well as Crohn's disease, and ulcerative colitis.

Drug development credit: Gorodenkoff Shutterstock Prilenia signs deal for former Teva ALS drug worth up to €500m

In the commercialization deal, Spanish pharmaceutical company Ferrer will receive the rights to market the drug in Europe, while the US market will remain in Prilenia's hands.

Healthcare credit: Tali Bogdanovsky Shutterstock Astrazeneca sets up Tel Aviv center to study Israeli health data

The UK pharmaceutical giant is teaming with Tel Aviv University and the Meuhedet and Leumit health funds on the project.

Healthee team credit: Healthee PR AI healthcare costs management co Healthee raises $50m

Healthee’s benefits and care navigation platform empowers employees and employers to make the most of their health benefits.

Roy Goldenberg  credit: Jonathan Bloom Making a better world for the disabled

Personal experience motivated Roy Goldenberg to become Israel director of TOM Tikkun Olam Makers. "TOM will be one of the biggest organizations to come out of Israel," he says.

Dr. Adi Tzoref-Lorenz credit: Jonathan Bloom "My research says I don't accept there is no answer"

The death of a cancer patient spurred Dr. Adi Zoref-Lorenz into developing the OHI index, which allows the diagnosis of the HLH side effect from cancer immunotherapy, based on two blood tests.

NextFerm technologies based on yeast credit: NextFerm Food-tech co NextFerm suspends operations

The company, which produces food ingredients in yeast without genetic engineering, cannot pay its debts and is seeking a buyer.

Insightec COO and general manager Eyal Zadicario credit: Ness Productions After 25 years of losses Insightec focuses on profit

Insightec COO and general manager Eyal Zadicario tells "Globes" about himself and the Israeli ultrasound company's long battle to change the medical world.

Navina founders Ronen Lavi and Shay Perera credit: Eyal Izhar Israeli clinical AI co Navina raises $55m

Navina equips clinicians and care teams with real-time, data-driven insights that improve the quality of care and financial outcomes.

Dr. Ola Gutzeit  credit: Ketty Hakim The doctor breaking new ground in fertility

"We know nothing about the female reproductive system," says Dr. Ola Gutzeit of Rambam Hospital. She seeks to change that, and hence change IVF for the better.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018